Venetoclax generic Venetoclax is a BCL-2 (B - cell lymphoma 2) inhibitor which is prescribed for the treatment of a type of white blood cell cancer, chronic lymphocytic leukemia (CLL), in patients whose tumor cells lack a part of the 17th chromosome (a specific gene alteration known as 17p deletion). It is prescribed only for patients who received prior treatment for the cancer. Venetoclax mainly acts by inhibiting the action of the BCL-2 protein present in the cancer cells and kills the abnormal lymphocytes which are present in the blood and the bone marrow.
More Info about Venetoclax